首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Effect of Weikangfu Granule on the Physiopathologic Figure of Precancerosis of Gastric Mucosa in Patients of Chronic Gastritis with Pi-Deficiency Syndrome
【24h】

Effect of Weikangfu Granule on the Physiopathologic Figure of Precancerosis of Gastric Mucosa in Patients of Chronic Gastritis with Pi-Deficiency Syndrome

机译:胃康复颗粒对Pi缺乏综合征慢性胃炎患者胃黏膜癌前病变生理病理的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To study the physiopathologic basis of Weikangfu Granule (WKFG) in treating precancerosis of gastric mucosa in patients of chronic gastritis with Pi-deficiency syndrome (CG-PDS). Methods: One hundred and fifteen patients of CG-PDS who suffered from intestinal metaplasia (IM) and atypical hyperplasia (ATHP) of gastric mucosa, were divided into two groups. The treated group (n = 61) was treated by WKFG with its ingredients modified according to the syndrome type of patients. The control group (n = 54) was treated with Weishu granule. The histopathological and subcellular ultra-structural changes were detected by optical microscope, screening electronic microscope, transmission electronic microscope and histochemical staining; the nuclear and mitochondrial ultrastructure of gastric mucosa were analyzed with energy dispersion X-ray analyser and image analysis system. And the changes of cAMP, lipid peroxide (LPO), superoxide dismutase (SOD) before and after treatment in the treated group were measured and compared with those of the health control group consisting of 15 volunteers. Results: The symptomatic and pathological therapeutic effect in the treated group were significantly superior to those in the control group (P < 0.05). The contents of Zn, Cu, cAMP, SOD and ~3H-TdR LCT in gastric mucosa of the treated group before treatment were all lower than those of the healthy control group, yet all these indexes markedly increased after treatment, while serum LPO level, which increased before treatment was lowered after treatment. All the changes showed statistical significance (P < 0.05 or P < 0.01). Conclusion: WKFG can reverse IM and ATHP in patients of CG-PDS, and the effect may be realized by way of increasing the level of Zn, Cu, cAMP and SOD in gastric mucosa, promoting cell differentiation, enhancing cellular immunity and reducing oxygen free radicals and lipid peroxidation.
机译:目的:研究胃康复颗粒(WKFG)治疗Pi缺乏综合征(CG-PDS)慢性胃炎患者胃黏膜癌前病变的生理病理基础。方法:将115例患有胃黏膜肠上皮化生(IM)和非典型增生(ATHP)的CG-PDS患者分为两组。治疗组(n = 61)接受WKFG治疗,其成分根据患者的综合征类型进行了修改。对照组(n = 54)用微舒颗粒治疗。光学显微镜,筛选电子显微镜,透射电子显微镜和组织化学染色检测组织病理学和亚细胞超微结构变化。用能量色散X射线分析仪和图像分析系统分析了胃黏膜的核和线粒体超微结构。并测量治疗组治疗前后cAMP,脂质过氧化物(LPO),超氧化物歧化酶(SOD)的变化,并与15名志愿者组成的健康对照组进行比较。结果:治疗组的症状和病理治疗效果明显优于对照组(P <0.05)。治疗前胃黏膜中Zn,Cu,cAMP,SOD和〜3H-TdR LCT的含量均低于健康对照组,但治疗后所有这些指标均明显升高,而血清LPO水平,治疗前增加,治疗后降低。所有变化均具有统计学意义(P <0.05或P <0.01)。结论:WKFG可以逆转CG-PDS患者的IM和ATHP,其作用可能是通过增加胃粘膜中Zn,Cu,cAMP和SOD的水平,促进细胞分化,增强细胞免疫性和减少无氧量来实现的。自由基和脂质过氧化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号